Please visit our MS learning channel on YouTube, which provides hundreds of MS related topics from many of our video recorded education programs and archived here: -- Be empowered with MS views and news. Opt-in with us:

~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Thursday, November 5, 2015

Psychiatric Comorbidity Among Multiple Sclerosis Patients Reported to Be Common

<span class="entry-title">Psychiatric Comorbidity Among Multiple Sclerosis Patients Reported to Be Common</span><span class="entry-subtitle">Compared to women, men with MS face a disproportionately greater relative burden of depression</span>

November 3, 2015

Psychiatric comorbidity is common in patients with multiple sclerosis (MS), and affects the MS community more frequently than a matched control population, although the incidence is stable over time, according to recent findings of a study published in the journal Neurology, the Official Journal of the American Academy of Neurology. In the study, researchers also reported that compared to women, men face a disproportionately greater relative burden of depression when they develop MS.
Depression and anxiety reduce the quality of life in patients with MS, and depression has been found to be associated with reduced persistence to disease-modifying therapy. While such adverse effects of psychiatric comorbidity are recognized in MS patients, its epidemiology remains poorly investigated.
With the goal of comparing the prevalence and incidence of psychiatric comorbidity in patients with MS to age, sex, and geographic area matched controls, in the study entitled “Differences in the burden of psychiatric comorbidity in MS vs the general population,” Ruth Ann Marrie, MD, PhD, and colleagues used data from four Canadian provinces and identified 44,452 MS patients and 220,849 matched controls. The team investigated the prevalence and incidence of bipolar disorder, anxiety, depression, and schizophrenia between 1995 and 2005.

MS Views and News helps to provide information for all affected by MS
Keep up to date with the news and information we provide 
by signing up by clicking here

No comments: